The dystrophin-glycoprotein complex is a large complex of membrane-associated proteins linking the cytoskeleton to the extracellular matrix in muscle. Transmembrane heterodimeric (␣␤) integrins serve also as cellular adhesion molecules and mechanotransducers. In the animal model for Duchenne muscular dystrophy, the mdx mouse, loss of dystrophin causes more severe abnormalities in skeletal than in cardiac muscle. We hypothesized that ablation of cardiac myocyte integrins in the mdx background would lead to a severe cardiomyopathic phenotype. Mdx mice were crossed to ones with cardiac myocyte-specific deletion of ␤1 integrin (␤1KO) to generate ␤1KOmdx. Unstressed ␤1KOmdx mice were viable and had normal cardiac function; however, high mortality was seen in peri-and postpartum females by 6 months of age, when severe myocardial necrosis and fibrosis and extensive dystrophic calcification was seen. Decreased ventricular function and blunted adrenergic responsiveness was found in the ␤1KOmdx mice compared with control (Lox/Lox, no Cre), ␤1KO, and mdx. Similarly, adult ␤1KOmdx males were more prone to isoproterenol-induced heart failure and death compared with control groups. Given the extensive calcification, we analyzed transcript levels of genes linked to fibrosis and calcification and found matrix ␥-carboxyglutamic acid protein, decorin, periostin, and the osteoblast transcription factor Runx2/Cbfa1 significantly increased in ␤1KOmdx cardiac muscle. Our data show that combined deficiency of dystrophin and integrins in murine cardiac myocytes results in more severe cardiomyopathic changes in the stressed myocardium than reduction of either dystrophin or integrins alone and predisposes to myocardial calcification. (Circ Res. 2008;102:1109-1117.) 
T he cardiac myocyte cytoskeleton and contractile apparatus are tethered to the sarcolemma at specialized regions termed costameres, which are aligned with the Z-disk. 1 Costameres are important for lateral force transmission from the sarcomere to the extracellular matrix (ECM) and from 1 myocyte to the next. 2 Three different cytoskeleton networks comprise the costamere: the dystrophin glycoprotein complex (DGC), the integrins, and the spectrinbased cytoskeleton.
The DGC is composed of several membrane-spanning and associated proteins and is enriched in, but not restricted to, costameric regions. 2, 3 In muscle, the DGC includes dystrophin, sarcoglycans (␣, ␤, ␥, ␦, , and ), dystroglycans (␣ and ␤), ␣-dystrobrevin, syntrophins (␣1, ␤1 and ␤2), sarcospan, and NO synthase. Dystrophin is a 427-kDa protein that constitutes a core component of the DGC. Mutations in the human dystrophin gene lead to Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, and X-linked dilated cardiomyopathy. 4 In mice, an X-linked recessive mutation in the dystrophin gene (mdx) results in loss of dystrophin expression, destabilization of the DGC, and muscular dystrophy. Whereas cardiomyopathy may occur early in the life of patients with muscular dystrophy, dilated cardiomyopathy occurs only in older unstressed mdx animals, eg, 42 weeks of age. 5 However, the mdx heart is susceptible to injury when challenged by mechanical or chemical stressors. 6 Furthermore, combined loss of dystrophin and utrophin (a dystrophin homolog) results in worsening of the cardiac phenotype. 7 Interestingly, the cardiomyopathic features of the dystrophin/utrophin double knockout can, in part, be prevented by transgenic overexpression of dystrophin in cardiomyocytes but not in the vasculature, indicating a direct link between dystrophin deficiency and cardiac myocyte pathology. 8 In addition to DGC proteins, the integrins are also enriched in the cardiac myocyte costamere, where they serve important structural and signaling functions. 9 Integrins provide for adhesion of cells to the ECM and act as mechanotransducers, converting mechanical stimuli to biochemical ones. 10 ␤1 integrins are the dominant ␤ integrin subunits found in cardiac and skeletal muscle. Muscle integrins, particularly those of the ␣7␤1 heterodimer, together with the DGC, constitute 2 major cellular adhesion systems that provide a physical link between the intracellular cytoskeleton and the ECM.
The DGC and integrin complexes may have overlapping functions, in that: (1) deficiencies of each caused various myopathies; (2) combined deficiency led to an accelerated skeletal muscular dystrophy 11 ; and (3) with loss of dystrophin, integrin expression increased in mouse models and patients. 12 The majority of this work has focused on skeletal muscle. Little data are available testing the functional role of both the DGC and integrins specifically in the cardiac myocyte. Therefore, we designed the present study to test the hypothesis that ablation of both systems in cardiac myocytes would lead to more severe cardiomyopathy than in mdx or cardiac-myocyte specific integrin ␤1 knockout mice, alone.
Materials and Methods
An expanded Materials and Methods section is available in an online supplement at http://circres.ahajournals.org.
Animals
Mice with ventricular myocyte specific excision of the ␤1 integrin gene were generated as previously described. 13 To generate mice lacking both ␤1 integrin expression and dystrophin expression, ␤1 knockout (␤1KO) mice were mated to mdx mice (C57BL/10ScSn-Dmdmdx/J) (The Jackson Laboratory, Bar Harbor, Me). All animal study protocols were approved by the institutional review committee, and all mice were housed in an AALAC-approved facility.
Antibodies
Primary antibodies used were as follows: rabbit polyclonal: anti-␤1D integrin 13 ; anti-integrin ␣7B 14 ; anti-integrin ␣5 (AB47 provided by Dr Maria Valencik) 15 ; mouse monoclonal: anti-dystrophin (NCL-DYS1, Novocastra Laboratories, Newcastle On Tyne, UK); anti-␣ sarcoglycan (NCL-L-␣-SARC, Novocastra); anti-utrophin (BD Pharmingen, San Diego, Calif); anti-GAPDH (Santa Cruz Biotechnology, Santa Cruz, Calif); anti-␣-tubulin (Sigma, St Louis, Mo); anti-myomesin (provided by Dr J.-C. Perriard). 16 
Results

Expression of Integrin and DGC Proteins in ␤1KOmdx Mice
We first examined the expression of integrin and DGC proteins in whole heart from 2-to 4-month-old animals. Animals doubly deficient in both dystrophin and ␤1 integrin (␤1KOmdx) were compared with mice singly deficient in either dystrophin or ␤1 integrin (mdx or ␤1KO, respectively) or ones with normal expression of proteins in the DGC and integrin complexes (F/F, control). As shown previously, 13 cardiac myocyte-specific inactivation of the floxed integrin ␤1 gene resulted in significant protein reduction by 8 weeks of age (33.8Ϯ12% versus control) ( Figure 1A and 1D). Concomitant with the reduction in ␤1D protein expression, the dominant ␣ integrin subunits expressed in the cardiac myocyte, ␣5 and ␣7 integrin, were reduced to Ϸ30% of control in ␤1KO hearts ( Figure 1B through 1D ). Although the ␤1KOmdx hearts had comparable reduction in ␤1D protein (25Ϯ11% versus control), expression of ␣5 and ␣7 integrins were at, or slightly above, control levels (119Ϯ25% and 132Ϯ27% of control, respectively; significantly different from ␤1KO). ␤1D, ␣5, and ␣7 integrin protein expression was either at or slightly above the control level in the mdx mice. ␣7 integrin was localized in cardiac myocytes ( Figure  I in the online data supplement). Thus, when the myocyte is deficient in both dystrophin and ␤1 integrin, ␣5, and ␣7 subunit expression is maintained.
Cardiac muscle of mdx and ␤1KOmdx mice did not have detectable levels of dystrophin or ␣-sarcoglycan protein, Figure 1 . Western blotting performed on whole heart lysates from 2-to 3-month-old females shows decreased ␤1D, ␣5, and ␣7 integrins in ␤1KO, whereas in ␤1KOmdx, only ␤1D integrin was reduced. A, Integrin ␤1D (Int ␤1D). B, Integrin ␣5 (Int ␣5). C, Integrin ␣7 (Int ␣7). D, Representative Western blots show reduced dystrophin (Dyst) and ␣-sarcoglycan (␣-SG) in mdx and ␤1KOmdx, whereas utrophin (Utr) expression was increased; no change was found in ␤-dystroglycan (␤-DG) expression. All data are presented as percentages of F/F control. All densitometric measurements were normalized to GAPDH or (in the case of integrin ␣ subunits, for which SDS-PAGE was run under nonreducing conditions) to Ponceau S stain. *PϽ0.05 vs F/F control, ⌽PϽ0.05 vs ␤1KO, PϽ0.05 vs mdx (nϭ3 to 6).
whereas utrophin was upregulated; ␤-dystroglycan expression was similar in all 4 groups ( Figure 1D and supplemental Figure II ).
Significant Myocardial Calcification Is Detected in ␤1KOmdx Females Despite Only Minimal Changes in Cardiac Function
We next examined the morphometry, histology and function of the hearts from 2-month-old female mice. As is shown in Table I in the online data supplement, morphometry showed that the mdx gene mutation lead to significant reduction in body weight and heart weight (HW), and the normalized HW (HW/tibial length) was significantly lower in the mdx and ␤1KOmdx groups compared with F/F and ␤1KO. Cardiac morphology revealed calcified lesions in 3 of 7 ␤1KOmdx hearts but not in any of the other groups. Histological examination showed focal areas with exten-sive myocyte replacement, inflammatory infiltrate, and calcium precipitation in only the ␤1KOmdx hearts ( Figure  2A through 2D).
Cardiac hemodynamics were examined using invasive catheterization (supplemental Table II ). Basally, the ␤1KOmdx mice showed significant decreases only in cardiac developed pressure and cardiac relaxation (dP/dt min ) (20% and 24%, respectively, compared with F/F control). Cardiac contractility (dP/dt max ) and heart rate were similar in all groups. Like the ␤1KOmdx mice, the singly deficient ␤1KO mice had decreased developed pressure and dP/dt min (21% and 24%, respectively). Mdx mice had a minimal decrease in dP/dt min only. ␤-Adrenergic responsiveness was preserved in all groups (Figure 2E through 2H) . Thus, the ␤1KOmdx mice have only minimal alterations of cardiac hemodynamics at 2 months of age despite the presence of focal myocyte replacement and fibrotic calcification. 
. Calcified tissue appears as dark purple using hematoxylin/eosin (H&E) stain. Scale barϭ150 m. E through H, Hemodynamic analysis performed by invasive catheterization showed normal responsiveness to dobutamine with no differences between groups. E, dP/dt max . F, dP/dt min . G, LV systolic pressure. H, Heart rate (HR). F/F, nϭ4; ␤1KO, nϭ5; mdx, nϭ4; ␤1KOmdx, nϭ7.
Pregnancy-Induced Volume Overload Leads to Deterioration in Cardiac Function, Decreased Sensitivity to ␤-Adrenergic Stimulation, Fibrosis, and Extensive Myocardial Calcification in ␤1KOmdx Females
Given the basal findings, we evaluated how stress might alter the cardiac function of the doubly deficient mice. Pregnancy is a state in which high volume and low vascular resistance lead to mild hypertrophic growth with an increased cardiac output as a means for compensation. 17 When the ␤1KOmdx females were subjected to the increased hemodynamic load of pregnancy, they were more susceptible to heart failure. The ␤1KOmdx females often died during gestation and did not survive long following parturition. Following this observation, we performed hemodynamic measurements on peripartum ␤1KOmdx mice. As is shown in the Table, dP/dt max and dP/dt min were reduced by Ϸ35% and Ϸ43%, respectively, compared with control mice, indicating significantly reduced systolic and diastolic function, respectively. There was a small decrease in dP/dt min in the ␤1KO group; a statistically significant difference between this group and the ␤1KOmdx group was not found. Although diastolic function as assessed by dP/dt min was affected, relaxation time and the relaxation time constant were not changed in the ␤1KOmdx. As shown in Figure 3 , in contrast to F/F, ␤1KO, and mdx mice, the peripartum ␤1KOmdx mice had a blunted response to ␤-adrenergic stimulation.
Given our morphometric and histological findings in the baseline state, we examined hearts from the mice in the peripartum period. No significant morphometric hypertrophy was found (supplemental Table III ). Histology showed extensive fibrosis and calcification ( Figure 4 ). To determine whether apoptotic cell death was causal in these findings, TUNEL assays were performed but no differences were found between groups (data not shown).
Chronic Isoproterenol Treatment Leads to Increased Mortality and Heart Failure in Young ␤1KOmdx Males
Given the findings with pregnancy, we studied mice subjected to a second type of stress administered by chronic infusion of isoproterenol (Iso). We studied 2-to 3-month males. Baseline echocardiography revealed smaller left ventricular (LV) diastolic dimensions as well as reduced LV mass in mdx and ␤1KOmdx compared with F/F and ␤1KO mice, suggesting an overall smaller heart in the presence of the mdx mutation (supplemental Table IV ). This observation is consistent with that found in 2-month-old females, in which HW and HW/tibial length were significantly smaller (by Ϸ20% and 15%, respectively) in these two groups compared with F/F and ␤1KO (supplemental Table I ). Iso was then administered for 14 days at the rate of 30 mg/kg day via osmotic pumps. Increased mortality in the ␤1KOmdx and ␤1KO mice was evident soon after the initiation of the infusion. All surviving mice were followed by echocardiography at days 7 and 14 of treatment. By day 7, echocardiography revealed a significant decrease in fractional shortening in the ␤1KOmdx, whereas F/F control, ␤1KO, and mdx groups experienced a slight, insignificant increase in fractional shortening, suggesting a state of compensatory response ( Figure 5A and 5B and supplemental Table IV ). In addition, by 14 days, LV wall dimensions (intraventricular septum and LV posterior wall thickness) increased significantly over baseline in all groups except for ␤1KOmdx ( Figure 5C and 5D ). Morphometry in the surviving mice were in line with these echo findings (supplemental Table V) . Enlarged RV chamber size was also evident in 2 of the surviving ␤1KOmdx mice ( Figure 5E ) but was not evident in other groups.
Survival of the ␤1KOmdx mice was 50%, and the ␤1KO group was 86% compared with 100% of the F/F and mdx groups ( Figure 6A ). Histological examination of Iso-treated mice revealed myocardial damage in all Iso-treated groups regardless of genotype; however, as demonstrated in Figure  6B , Iso-treated ␤1KOmdx hearts revealed areas of severe fibrosis and extensive myocyte damage.
Expression of Regulators of a Calcification Program
Although observed often in skeletal muscle of dystrophic mdx mice, 18 ectopic calcification has not been noted in the heart Mice were 6 -8 months. Measurements, which were obtained 1 month following parturition, showed reduced systolic and diastolic function in ␤1KOmdx mice. Data are presented as meansϮSEM. CI indicates contractility index (dP/dt max /pressure); DP, developed pressure; LVSP, LV systolic pressure; RT, relaxation time; TTI, tension-time index (area under LV pressure during ejection phase of contraction); , time constant of isovolumic LV pressure decay. *Significantly different compared with F/F, control, PϽ0.05;
†significantly different compared with ␤1KO, PϽ0.05; ‡significantly different compared with mdx, PϽ0.05.
muscle of muscular dystrophy animal models. The calcification process has been most extensively studied in relation to the development of atherosclerotic plaques. In the vessel, it has been proven to be an active and regulated process 19 linked to mediators of bone formation, including matrix ␥-carboxyglutamic acid protein (MGP), decorin, periostin, Runx2/Cbfa1, bone morphogenetic protein, and alkaline phosphatase. Given this, we evaluated transcript expression of these mediators in cardiac tissue from our mice using real-time RT-PCR ( Figure 7 ). Levels of MGP were upregulated 10-fold in ␤1KOmdx hearts compared with other groups (Figure 7A ). Decorin mRNA levels were increased 6-fold in ␤1KOmdx hearts compared with F/F controls, whereas the single KO ␤1KO hearts and mdx hearts had 3-fold more transcript compared with control ( Figure 7B ). We observed a trend toward an increase in decorin transcript levels in the ␤1KO, mdx, and ␤1KOmdx groups; however, statistically significant differences were not found among these groups ( Figure 7B ). mRNA levels of periostin and Runx2/Cbfa1 were increased Ϸ10-fold in the ␤1KOmdx hearts compared with F/F controls ( Figure 7C and 7D) . Expression levels of bone morphogenetic protein-2 (the classic mediator of osteoblast differentiation), alkaline phosphatase, and osteocalcin were not significantly different between any of the groups (data not shown).
Discussion
Costameric regions of cardiac myocytes consist of protein networks that form physical attachment points between the Z-disks of the cell and the ECM. 20 Functionally, the costamere is thought to transmit contractile forces laterally from the sarcomere, across the membrane and the ECM, to neighboring cells. 21 Although not specific to the region, both dystrophin and integrins are enriched in costameric regions.
Here, we hypothesized that ablation of integrin ␤1 and dystrophin in cardiac myocytes would result in a severe cardiomyopathy. Our animal model is the first to cause cardiac myocyte specific reduction of the integrin ␤1 protein in the mdx mice. In doing so, we found that systolic dysfunction occurs following either pregnancy, a state of volume overload, or with chronic ␤-adrenergic receptor stimulation. Furthermore, we found histological evidence of cardiac calcification. We then examined expression of key regulators of the mineralization process. These transcripts are upregulated during vascular calcification, yet in cardiac tissue from our mice, only a subset of transcripts (MGP, decorin, periostin, and Runx2/Cbfa1) were increased, whereas bone morphogenetic protein, alkaline phosphatase, and osteocalcin were not changed. This implies that the dystrophic calcification process in the myocardium is distinct from but shares some features with the vascular one. Absence of dystrophin from skeletal muscle leads to an increase in ␣7 integrin expression. 12 In contrast, ␣7 expression was decreased in laminin ␣2 chain muscular dystrophy in both man and mouse (dy/dy mice). 12 Furthermore, global knockout of murine integrin ␣7 results in a distinct form of muscular dystrophy characterized by muscle fiber necrosis and degeneration, variable fiber size, and the presence of central nuclei. 22 Absence of integrin ␣7 in mdx mice leads to a more severe skeletal muscle pathology than either integrin ␣7-null or mdx mice alone. 11 Given that integrin-and DGC-mediated ECM-cytoskeleton linkages can functionally overlap, it was hypothesized that upregulation of ␣7 integrin protein in muscle with dystrophin deficiency occurs as a compensatory process. Supporting this premise were data showing that a 2-fold overexpression of integrin ␣7 in mice that lack both dystrophin and utrophin (mdx/utr Ϫ/Ϫ ) attenuated skeletal muscle pathology and extended the lifespan of the animal. 23 Global knockout of the integrin ␣7 gene alone or in the mdx background (␣7/mdx) showed no parallel reduction in integrin ␤1D expression nor a change in its cellular localization. 11, 22 In contrast, we found that ␣7 protein expression was significantly reduced in parallel with ␤1 integrin reduction in ␤1KO hearts. However, ␣7 protein expression was increased above control levels in mdx as well as in the doubly deficient ␤1KOmdx hearts. Thus, the results from our study and from this previous work suggest that when either integrin ␣ or ␤ subunits are reduced, the partner can be properly expressed and localized in the cell. Of importance is that cardiac myocyte ␤1 integrin can partner with several ␣ subunits in addition to ␣7 integrin. In this regard, we found that both ␣5 and ␣7 protein levels were reduced in the single ␤1KO hearts, whereas both ␣ subunits were expressed at or above wildtype levels in the ␤1KOmdx mice. As mentioned above, the increase in ␣7 integrin expression in DMD patients and in mdx mice is thought to be regulated transcriptionally, whereas its decrease in our ␤1KO animals is most probably attributable to protein degradation. It has been shown that most members of the DGC are absent in dystrophin deficiency. In contrast, utrophin, a 376-kDa dystrophin homolog, is increased and has altered intracellular distribution in muscle of DMD and Becker muscular dystrophy patients as well as in mdx mice. 24, 25 Deficiency in both dystrophin and utrophin results in more severe cardiac muscle contractile dysfunction than dystrophin deficiency alone 26 and expression of a full-length or a truncated form of utrophin markedly improves dystrophic muscle pathology in mdx mice. 27 As in other dystrophic models, utrophin was upregulated in hearts of our ␤1KOmdx animals. Thus, the normal expression of ␣7 integrin, combined with the compensatory increase in utrophin in the ␤1KOmdx hearts, may allow for the delayed and conditional onset of the cardiac dysfunction in the absence of integrin ␤1 and dystrophin in our model.
In heart failure, increased activation of the sympathetic system leads to ␤-adrenergic receptor downregulation or uncoupling from G s , along with an increase in G ␣i . 28, 29 Furthermore, our prior work has linked ␤ 1 integrins to the modulation of ␤-adrenergic receptor signaling. 30 Disruption of ␤ 1 integrin signaling in the cardiac myocyte leads to augmentation of Iso-induced stimulation of L-type Ca current (I Ca ), and overexpression of ␤ 1A integrin decreased Isoinduced stimulation of I Ca . Thus, the loss of ␤ 1 integrin expression and function may enhance ␤-adrenergic responsiveness to agonists leading to augmentation of I Ca . The combination of the integrin-mediated defect, with the dysregulation of Ca ϩ2 homeostasis found in dystrophic muscle, may explain why more severe calcification is found in our doubly deficient ␤1KOmdx mice than those with loss of ␤ 1 integrin or dystrophin alone.
The presence of calcified lesions in the myocardium of ␤1KOmdx mice is an early event that is independent of abnormal cardiac loading conditions. Although an unusual finding in myocardium of animal models with cardiovascular disease, cardiac calcification is encountered in myocardial freeze-thaw injury model, 31 in acute myopericarditis resulting from cytomegalovirus infection, 32 and in some genetically manipulated models of cardiomyopathy, such as that with increased L-type Ca 2ϩ channel activity. 33 The most striking examples of myocardial calcification are observed with murine global knockout of the intermediate filament desmin in mice with cardiac myosin-binding protein-C gene mutations, as well as in the Syrian hamster model of cardiomyopathy. 34 -36 The desmin-null mice lack desmin in smooth, skeletal, and cardiac muscle, but damage to cardiac muscle is independent of damage to the vasculature. 37 Electron microscopic analysis revealed severe mitochondria swelling/disintegration and disorganization in desmin-null cardiomyocytes. 35 Given the extensive damage to mitochondria, it was proposed that the mitochondria might constitute the nidus in which calcified deposits first appear attributable to a disturbance in intracellular Ca ϩ2 homeostasis. Interestingly, mutation of a member of the DGC, ␦-sarcoglycan, is found in the Syrian hamster and is likely causal in the myocardial disease because this mutation may predispose to sarcolemma membrane damage. 36 Extensive studies have been performed on calcium homeostasis of dystrophin-deficient skeletal muscle from patients, as well as mdx mice. Some demonstrate increased intracellular Ca ϩ2 concentrations [Ca ϩ2 ] i in dystrophic muscle, whereas others did not. This discrepancy is likely attributable to the variability in localizing excess Ca ϩ2 in the subsarcolemmal region by different techniques. 38 Two studies showed increased resting [Ca ϩ2 ] i in cardiac muscle cells of mdx mice. 39 This change was attributed to several findings: (1) increased expression of the ryanodine receptor; (2) decreased expression of serine-16 -phosphorylated phospholamban; (3) increased function of the Na ϩ /Ca 2ϩ exchanger; and possibly (4) increased activity of stretch-activated channels. In addition a drastic decrease in the sarcoplasmic reticulum luminal Ca 2ϩ -binding proteins calsequestrin and sarcalumenin were found in cardiac muscle of mdx mice indicating impaired sarcoplasmic reticulum Ca 2ϩ -buffering capacity. Although it has not been shown in cardiac muscle, dystrophic skeletal muscle has persistently activated Ca ϩ2 leak channels and these are introduced into the damaged membrane during the natural membrane resealing process. Their function is thought to replete internal Ca ϩ2 stores. 40 Thus, it appears that the dystrophic myocyte is prone to calcium loading and myocyte injury resulting in tissue calcification as we found in the present study.
Historically the process of calcification was regarded as a passive and degenerative process; however, recent studies, dominantly in atherosclerotic disease, have shown it to be an active and regulated process. 19 The major hypothesis from this work attributes an important role for osteoblast-type cells (arising from a phenotypic change in vascular smooth muscle cells or activation of resident mesenchymal-like or circulating stem cells), which orchestrate a process of bone formation. 19 To date, no studies have pursued the basis for the calcification process or the identification of candidate cell types responsible for it in the myocardium.
On examination of our model for potential mediators involved in myocardial calcification, we observed that MGP, decorin, periostin, and Runx2/Cbfa1 transcript levels were significantly increased in hearts of ␤1KOmdx mice. MGP is a mineral-binding ECM protein produced by vascular smooth muscle cells, as well as chondrocytes, that shows increased expression in human atherosclerotic plaques. 41 Its overexpression in our model suggests that its inhibitory function can be overwhelmed as occurs in vascular tissue. 19 Periostin is a secreted protein that was initially thought to be bone-specific and required for osteoblast differentiation. However, recent investigations have shown that periostin is expressed in the developing heart and that it has an antiosteogenic effect. 42 Increased expression of periostin in patients with heart failure, as well as in animal models of cardiac remodeling, has been reported, 43, 44 although its specific function is not yet known. The significant increase in Runx2/Cbfa1 transcript, a member of the runt/Cbfa family of transcription factors and a key regulator of osteoblast differentiation, is of particular interest. Runx2/Cbfa1 is a nuclear factor that activates several major osteoblast specific genes such as osteocalcin, bone sialoprotein, osteopontin, and ␣1-type collagen. 45 Moreover, induced expression of Runx2/Cbfa1 in nonosteoblast cells such as fibroblasts activates the expression of osteocalcin and bone sialoprotein, indicating a role for Runx2/Cbfa1 in inducing cells toward osteoblast-like differentiation. Further analysis of the role of Runx2/Cbfa1 in dystrophin/integrin deficiency is necessary.
Our results show that the observed calcification shares some molecular features with mineralized vascular plaques and indicates that this mineralization process is not simply a disordered degenerative event but one involving de novo gene transcription of key mediators and inhibitors of the process. This study is the first presenting a link between combined DGC and integrin complex insufficiency and myocardial calcification.
